Comparative Analysis of Clinical Efficacy and Safety of Pyrotinib Plus Capecitabine versus Trastuzumab Emtansine (T-DM1) as Second-Line Treatment for HER2-Positive Advanced Breast Cancer: A Retrospective Study

Han H, Wang C, Jiang F, Sun P, Liu J

Drug Design, Development and Therapy 2025, 19:2885-2895

Published Date: 14 April 2025